Literature DB >> 29301766

Population-based assessment of visual acuity outcomes following cataract surgery in Australia: the National Eye Health Survey.

Stuart Keel1, Jing Xie1, Joshua Foreman1,2, Hugh R Taylor3, Mohamed Dirani1,4.   

Abstract

AIM: To assess the visual outcomes of cataract surgery among a national sample of non-Indigenous and Indigenous Australians.
METHODS: This was a population-based study of 3098 non-Indigenous Australians (50-98 years) and 1738 Indigenous Australians (40-92 years), stratified by remoteness. A poor postoperative outcome in an eye that had undergone cataract surgery was defined as presenting distance visual acuity (PVA) <6/12-6/60, and a very poor outcome was defined as PVA <6/60. Effective cataract surgery coverage (eCSC; operated cataract and a good outcome (PVA ≥6/12) as a proportion of operable plus operated cataract) was calculated.
RESULTS: The sampling weight adjusted cataract surgery prevalence was 19.8% (95% CI 17.9 to 22.0) in non-Indigenous Australians and 8.2% (95% CI 6.0 to 9.6) in Indigenous Australians. Among the non-Indigenous population, poor and very poor PVA outcomes were present in 18.1% and 1.9% of eyes, respectively. For Indigenous Australians, these values were 27.8% and 6.3%, respectively. The main causes of poor vision were refractive error (non-Indigenous=41.8%; Indigenous=41.9%) and coincident disease (non-Indigenous=43.3%; Indigenous=40.3%). The eCSC rates in the non-Indigenous and Indigenous populations were 88.5% (95% CI 85.2 to 91.2) and 51.6% (95% CI 42.4 to 60.7), respectively.
CONCLUSION: Approximately half of eyes with a poor visual outcome postcataract surgery could be readily avoided through the appropriate refractive correction. The finding of a lower eCSC rate among Indigenous Australians suggests that improvements in access and quality of cataract services may be warranted in order to reduce cataract-related vision loss in the Indigenous population. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  epidemiology; public health

Mesh:

Year:  2018        PMID: 29301766     DOI: 10.1136/bjophthalmol-2017-311257

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Grand Challenges in global eye health: a global prioritisation process using Delphi method.

Authors:  Jacqueline Ramke; Jennifer R Evans; Esmael Habtamu; Nyawira Mwangi; Juan Carlos Silva; Bonnielin K Swenor; Nathan Congdon; Hannah B Faal; Allen Foster; David S Friedman; Stephen Gichuhi; Jost B Jonas; Peng T Khaw; Fatima Kyari; Gudlavalleti V S Murthy; Ningli Wang; Tien Y Wong; Richard Wormald; Mayinuer Yusufu; Hugh Taylor; Serge Resnikoff; Sheila K West; Matthew J Burton
Journal:  Lancet Healthy Longev       Date:  2022-01

Review 2.  The Peter Watson Memorial Lecture "Vision for the World".

Authors:  Hugh R Taylor
Journal:  Eye (Lond)       Date:  2022-04-08       Impact factor: 3.775

Review 3.  Refractive Outcomes after Cataract Surgery.

Authors:  Ramin Khoramnia; Gerd Auffarth; Grzegorz Łabuz; George Pettit; Rajaraman Suryakumar
Journal:  Diagnostics (Basel)       Date:  2022-01-19

Review 4.  Considerations for Training and Workforce Development to Enhance Rural and Remote Ophthalmology Practise in Australia: A Scoping Review.

Authors:  Kehinde Obamiro; Belinda Jessup; Penny Allen; Victoria Baker-Smith; Santosh Khanal; Tony Barnett
Journal:  Int J Environ Res Public Health       Date:  2022-07-14       Impact factor: 4.614

5.  Interventions to improve the quality of cataract services: protocol for a global scoping review.

Authors:  Miho Yoshizaki; Jacqueline Ramke; João M Furtado; Helen Burn; Stephen Gichuhi; Iris Gordon; Ada Aghaji; Ana P Marques; William H Dean; Nathan Congdon; John Buchan; Matthew J Burton
Journal:  BMJ Open       Date:  2020-08-11       Impact factor: 2.692

6.  Global Blindness: The Progress We Are Making and Still Need to Make.

Authors:  Hugh R Taylor
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.